HumanavsJohnson & Johnson

HUM and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

Humana (HUM) has a market value of $54.3B and Johnson & Johnson (JNJ) $689B. Over the last year, with dividends, HUM moved +89.6% and JNJ +50.3%. The P/E is 43.6 for HUM and 42.8 for JNJ. Dividend yield: HUM 0.79%, JNJ 1.85%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HUM$54.3B

    JNJ$689B

    JNJ is 13 times HUM

  • Revenue, 12 months

    HUM$154B

    JNJ$99.3B

    HUM is 1.6 times JNJ

  • Net income, 12 months

    HUM$1.2B

    JNJ$16.1B

    JNJ is 13 times HUM

  • Operating margin

    HUM1.5%

    JNJ–

  • ROIC

    HUM5.7%

    JNJ12.4%

    6.7 points apart

  • P/E

    HUM43.6

    JNJ42.8

    About the same

  • Dividend yield

    HUM0.8%

    JNJ1.8%

    1.1 points apart

  • 5-year return

    HUM+6.2%

    JNJ+99.1%

    92.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HUM+6.2%

JNJ+99.1%

5010015020020222023202420252026
Returns by period
PeriodHUMWith dividendsJNJWith dividends
1 year since November 12, 2025+89.6%Price +87.1%+50.3%Price +47.0%
3 years since November 13, 2023-6.1%-2.1% a yearPrice -9.5%+110.8%+28.2% a yearPrice +93.6%
5 years since November 12, 2021+6.2%+1.2% a yearPrice +1.0%+99.1%+14.8% a yearPrice +73.2%
10 years since November 15, 2016+146.4%+9.4% a yearPrice +126.3%+222.3%+12.4% a yearPrice +145.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HUMHumanaJNJJohnson & Johnson

Valuation

HUMJNJ
Valuation
Price$450.00$285.75
Market value$54.3B$689B
Enterprise value (EV)$41.7B$716B
P/E43.642.8
P/E, 5-year median23.221.9
P/B2.98.5
EV/EBIT17.540.4
Free cash flow yield5.8%3.0%

Results and growth

HUMJNJ
Results and growth
Revenue, 12 months$154B$99.3B
Net income, 12 months$1.2B$16.1B
Free cash flow, 12 months$3.1B$20.6B
Earnings per share, 12 months$10.30$6.59
Revenue growth, year on year10.1%6.1%
Revenue growth a year, past+10.9%over 5 years+2.7%over 5 years
EPS growth a year, past-17.2%over 5 years+14.9%over 5 years

Margins and returns on capital

HUMJNJ
Margins and returns on capital
Gross margin–67.6%
Operating margin1.5%–
Net margin0.8%16.2%
ROIC5.7%12.4%
ROE6.7%19.7%

Balance sheet

HUMJNJ
Balance sheet
Cash$25.1B$17.2B
Total debt$12.5B$44.7B
Net debt / EBITDA-4.11.1
Interest cover3.2×18.0×

Dividends and buybacks

HUMJNJ
Dividends and buybacks
Dividend yield0.8%1.8%
Dividend per share, 12 months$3.54$5.28
Dividend growth a year, past+7.8%over 5 years+5.3%over 5 years
Buyback yield0.3%0.9%
Shareholder yield1.1%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HUM or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Humana or Johnson & Johnson?

By market value, Johnson & Johnson ($689B) is about 12.7 times Humana ($54.3B), at today's prices.

How did HUM and JNJ stock do over the last 10 years?

Since November 15, 2016, HUM's price moved +126.3% and JNJ's +145.7%. With dividends: HUM +146.4% (+9.4% a year), JNJ +222.3% (+12.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, HUM or JNJ?

The dividend yield at today's price is 0.79% for Humana and 1.85% for Johnson & Johnson. Over the last twelve months they paid $3.54 and $5.28 per share.

What is the P/E of HUM and JNJ?

At today's price, the P/E is 43.6 for HUM and 42.8 for JNJ. The median of the last five years was 23.2 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Humana or Johnson & Johnson?

Over the last twelve months, the net margin was 0.8% for Humana and 16.2% for Johnson & Johnson, and the operating margin 1.5% and –. Revenue was $154B and $99.3B.

Which is the better investment, Humana or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.